HealthFDA adds rare vision-loss warning to popular GLP-1 drugs
The FDA is adding a warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, including Ozempic.
FDA adds rare vision-loss warning to popular GLP-1 drugs
